Carbonic Anhydrases Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target
Coordonnateurs : Supuran Claudiu T., Nocentini Alessio
Carbonic anhydrases are universal metalloenzymes, existing in humans and most organisms, that catalyze the quick interconversion of carbon dioxide and water to bicarbonate and protons. The regular discovery of novel isozymes belonging to different CA classes and new CA modulators, as well as continuous findings regarding known isoforms of pharmaceutical interest, continually revitalizes CAs as an evergreen pharmaceutical target, relevant to cancer, neurologic, metabolic, immunologic, infectious, microbial, and pain disorders among others.
Carbonic Anhydrases: Biochemistry and Pharmacology of an Evergreen Pharmaceutical Target provides a detailed overview of CAs, spanning biochemical and structural features to pharmacology and drug-design, and also touching on the various biotechnological applications of these metalloenzymes. The book adopts a clear, step-by-step approach and introduction to this intricate and highly interdisciplinary field, first covering carbonic anhydrase classification (biochemistry and the structure of all CA classes), followed by their role as drug targets (pharmacology and drug design of carbonic anhydrase inhibitors and activators), and biotechnological applications of specific CA classes. A diverse range of chapters from international experts speak to carbonic anhydrase distribution, carbonic anhydrase families, human carbonic anhydrase, CA inhibitors and activators, CA zinc binders, zinc-bound nucleophile, and CA employed in treatment of glaucoma, epilepsy, obesity, neuropathic pain, arthritis, and infectious and fungal agents among other diseases and threats to human health.
- Features chapter contributions from international leaders in carbonic anhydrase-driven biochemical research and pharmacology
- Prepares active researchers (in academia and industry) and students to perform their own research in this intricate and highly interdisciplinary field
- Adopts a clear, step-by-step approach and introduction to this intricate and highly interdisciplinary field
Part 1: Introduction 1. Carbonic Anhydrases: An Overview
Part 2: Distribution, biochemistry, and structural features of Carbonic Anhydrase families 2. α-Carbonic Anhydrases 3. β-Carbonic Anhydrases 4: γ-Carbonic Anhydrases 5. δ-Carbonic Anhydrases 6. ζ-Carbonic Anhydrases 7: η and θ-Carbonic Anhydrases
Part 3: Carbonic Anhydrases as Drug Targets 8. Human Carbonic anhydrases: tissue distribution, physiological role and druggability 9. Mechanisms of action of Carbonic Anhydrase inhibitors: Zinc binders 10. Mechanisms of action of Carbonic Anhydrase inhibitors: compounds that anchor to the zinc-bound nucleophile 11. Mechanisms of action of Carbonic Anhydrase inhibitors: Compounds occluding the entrance of the active site 12. Mechanisms of action of Carbonic Anhydrase inhibitors: compounds that bind “out of the binding site and compounds with an unknown mechanism of action 13. Carbonic anhydrase inhibitors as ophthalmologic drugs for the treatment of glaucoma 14. Carbonic anhydrase inhibitors as diuretics 15. Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity 16. Carbonic anhydrase inhibitors for the treatment of tumors: therapeutic, immunologic, and diagnostic tools targeting isoforms IX and XII 17. Carbonic anhydrase inhibitors for the treatment of neuropathic pain and arthritis 18. Carbonic Anhydrases from pathogens: bacterial CAs and related inhibitors as potential anti-infectives 19. Carbonic Anhydrases from pathogens: fungal CAs and related inhibitors as potential anti-fungal agents 20. Carbonic Anhydrases from pathogens: protozoan CAs and related inhibitors as potential anti-protozoal agents 21. Carbonic Anhydrase Activators and their potential in the pharmaceutical field.
Part 4: Carbonic Anhydrases for Biotechnological Applications 22. CO2 Capture by engineered mammalian Carbonic Anhydrases 23. Biotechnological applications of Carbonic Anhydrases from extremophiles
Active researchers and students in biochemistry, molecular biology, pharmaceutical science, cellular biology, applied microbiology, and biotechnology; medical chemists; clinician scientists
Dr. Alessio Nocentini currently works at the Department of Neuroscience, University of Florence, Italy. He recently concluded his PhD thesis, which dealt with several aspects of carbonic anhydrase, spanning from drug-design, synthesis of inhibitors, and molecular modeling to biological evaluations of carbonic anhydrase modulators. He is now a post-doctoral researcher in Professor Supuran’s research team.
Date de parution : 09-2019
Ouvrage de 512 p.
À paraître, réservez-le dès maintenant
242,37 €Ajouter au panier